PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 30.00 | 0.27% | 10,954.00 | 10,962.00 | 10,964.00 | 11,012.00 | 10,890.00 | 10,934.00 | 824,680 | 16:35:10 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 27,668.9 | -196.0 | 5.9 | 1,655.6 | 169,690 |
Astrazeneca (AZN) News Headlines
Astrazeneca News
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/11/2022 | 15:30 | UKREG | AstraZeneca PLC Director/PDMR Shareholding |
| 14/11/2022 | 23:24 | DJN | ADRs End Mostly Lower, Infineon and Roche Trade Actively |
| 14/11/2022 | 09:38 | ALNC |  TOP NEWS: AstraZeneca receives three recommendations for EU approval |
| 14/11/2022 | 07:52 | DJN | AstraZeneca Says Enhertu Recommended for EU Approval for Gastric Cancer |
| 14/11/2022 | 07:49 | DJN | AstraZeneca's Imfinzi Plus Chemotherapy Recommended for Market.. |
| 14/11/2022 | 07:44 | DJN | AstraZeneca: Lynparza Combo Recommended in EU for Prostate Cancer |
| 14/11/2022 | 07:10 | UKREG | AstraZeneca PLC Enhertu recommended for EU approval in gastric |
| 14/11/2022 | 07:05 | UKREG | AstraZeneca PLC Imfinzi recommended for approval in the EU for BTC |
| 14/11/2022 | 07:00 | UKREG | AstraZeneca PLC Lynparza combo recommended in the EU for mCRPC |
| 11/11/2022 | 09:12 | ALNC | TOP NEWS: AstraZeneca wins US FDA approval for lung cancer drugs |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |